Antengene Corporation Investor Relations Material
Latest events
H1 2025
22 Aug, 2025
Study Update
20 Aug, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Antengene Corporation Limited
Access all reports
Antengene Corporation Limited is a China-based biotechnology company focused on the discovery, development, and commercialization of therapies for cancer and other life-threatening diseases. Antengene's work spans early-stage discovery through clinical development and regulatory approvals, with a focus on targeted therapies and immuno-oncology. It is headquartered in Shanghai, China, and its shares are listed on the HKEX.
Key slides for Antengene Corporation Limited
H2 2024
Antengene Corporation Limited
Jefferies Global Healthcare Conference 2025 Presentation
Antengene Corporation Limited
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
6996
Country
🇭🇰 Hong Kong